header image

What I Do

I am a doctor and a researcher, a physician and a clinician. I treat lymphoma patients and research new treatments for Hodgkin and non-Hodgkin lymphoma.

section image

Why I Do It

The relationship you have with people experiencing cancer is very intense. It’s a privilege to be that calm in the storm and be able to guide someone through that process.

section image

My Big Career Moment

I volunteered as a Spanish translator in a medical clinic in college. It was special to have this interaction and this relationship with people. It’s very intimate. The experience made me think: maybe this medicine thing is for me.

section image

‘It Just Clicked’: Caring for Patients and Researching Cures

10/11/2022 06:00am | 3975 views

“Like any good first-generation immigrant child, I was told I could be a lawyer or a doctor or go into business when I grew up. I wasn’t excited about law.” - That’s how Alex Herrera describes his earliest career ambitions.   

read more

About the mentor

profile logo image

Alex Herrera

Associate Professor, Division of Lymphoma
City Of Hope

Alex Herrera, M.D. is a hematologist-oncologist with City of Hope, specializing in Hodgkin and non-Hodgkin lymphoma. His clinical and research interests center on immunotherapy and hematopoietic stem cell transplantation in patients with lymphoma.

He is the principal investigator of more than 30 clinical trials evaluating novel agents for the treatment of Hodgkin or non-Hodgkin lymphomas, including 12 investigator-initiated trials. He also studies biomarkers of response and outcome in patients with lymphoma treated with immunotherapies or hematopoietic stem cell transplantation with the goal of designing biomarker-based clinical trials to improve outcomes and personalize lymphoma treatment.

Dr. Herrera earned his undergraduate degree summa cum laude from Princeton University and received his medical degree from Harvard Medical School. Dr. Herrera completed his residency in internal medicine at the Brigham and Women’s Hospital, before pursuing a hematology-oncology fellowship at the Dana-Farber Cancer Institute/Massachusetts General Hospital.